Perhaps the next best hope for a permanent way to defeat HIV is about to get underway. According to trial registration data, pharmaceutical company Moderna will start a Phase I clinical trial of its HIV vaccine candidate this week, based on the same mRNA platform behind its successful covid-19 vaccine. The trial will...
Perhaps the next best hope for a permanent way to defeat HIV is about to get underway. According to trial registration data, pharmaceutical company Moderna will start a Phase I clinical trial of its HIV vaccine candidate this week, based on the same mRNA platform behind its successful covid-19 vaccine. The trial will...
Share this Article
Recommended